Search For "adar poonawalla"
Updated : 1 week ago IST
China needs a good Covid 19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted next year.
Updated : 1 week, 1 day ago IST
The indigenously developed vaccine, "CERVAVAC" was announced for the prevention of cervical cancer.
Updated : 3 weeks, 2 days ago IST
Serum Institute of India CEO Adar Poonawalla on Monday said that the Covovax vaccine will get approval as a booster dose in the next 10 to 15 days.
Serum Institute of India CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.
Updated : 2 months, 1 week ago IST
As per the complaint, Satish Deshpande, one of the directors at the SII had received a message on WhatsApp from a person posing as SII CEO Adar Poonawalla and was asked to send money into seven different accounts in September 2022. Believing the message was from Poonawala, Deshpande transfer
Updated : 3 months, 2 weeks ago IST
Pune (Maharashtra) [India], October 20 (ANI): Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said that the medical firm stopped the production of the Covishield vaccine since December 2021.
Updated : 4 months ago IST
Pune (Maharashtra) [India], October 1 (ANI/BusinessWire India): Care Ratings Ltd (Care) has upgraded the long-term rating of Poonawalla Fincorp Limited (PFL) and its subsidiary, Poonawalla Housing Finance Limited (PHFL) to "CARE AAA (Triple A), Stable". This rating is applicable for bank loa
New Delhi [India], September 29 (ANI): The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is produced in India, said sources on Thursday.
Updated : 6 months, 3 weeks ago IST
New Delhi [India], July 12 (ANI): India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India (DCGI) approval for market authorisation. This vaccine will be manufactured by the Serum Institute of India (SII).
Updated : 8 months, 4 weeks ago IST
New Delhi [India], May 10 (ANI): The speculations of Tesla chief Elon Musk visiting India in near future gained traction after his Twitter remark post got viral.
Updated : 9 months ago IST
Pune (Maharashtra) [India], May 5 (ANI): Chief Executive Officer of Pune based Serum Institute of India Adar Poonawalla on Wednesday clarified that the COVID-19 vaccine Covovax is available for everyone above the age of 12 years.